RICCIARDI, GIUSEPPE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.118
EU - Europa 1.151
AS - Asia 270
AF - Africa 8
OC - Oceania 1
Totale 3.548
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.114
RU - Federazione Russa 477
PL - Polonia 216
IT - Italia 142
IE - Irlanda 125
SE - Svezia 111
SG - Singapore 80
HK - Hong Kong 78
CN - Cina 55
FI - Finlandia 28
DE - Germania 25
JO - Giordania 25
IN - India 21
UA - Ucraina 15
CI - Costa d'Avorio 7
VN - Vietnam 6
CA - Canada 4
GB - Regno Unito 4
NL - Olanda 3
BE - Belgio 2
JP - Giappone 2
PT - Portogallo 2
AU - Australia 1
CH - Svizzera 1
KG - Kirghizistan 1
MU - Mauritius 1
PK - Pakistan 1
TR - Turchia 1
Totale 3.548
Salva come PNG Salva come JPEG
Città #
Santa Clara 331
Fairfield 299
Warsaw 216
Ashburn 155
Chandler 142
Woodbridge 142
Seattle 129
Dublin 125
Cambridge 118
Houston 117
Wilmington 90
Singapore 68
Hong Kong 50
Ann Arbor 48
Jacksonville 43
Lawrence 42
Altamura 41
Princeton 34
Boston 27
Buffalo 26
San Diego 21
Beijing 20
Mumbai 20
Boardman 14
Medford 12
Florence 10
Falls Church 9
Kent 9
New York 9
Norwalk 9
Shanghai 9
Milan 8
Abidjan 7
Cagliari 4
Dong Ket 4
Moscow 4
Munich 4
Rome 4
West Jordan 4
Alba 3
Andover 3
Laurel 3
Yubileyny 3
Brussels 2
Calcinaia 2
Campi Bisenzio 2
Cantagallo 2
Capergnanica 2
Cesena 2
Cosenza 2
Empoli 2
Guangzhou 2
Los Angeles 2
Orenburg 2
Phoenix 2
Pisa 2
Poggibonsi 2
Porto 2
Scarperia e San Piero 2
Terni 2
Toronto 2
Washington 2
Anzio 1
Avellino 1
Bern 1
Bishkek 1
Brescia 1
Chicago 1
Frankfurt Am Main 1
Islamabad 1
Jinan 1
Leawood 1
Massa E Cozzile 1
Mcallen 1
Monte Di Procida 1
Montréal 1
Nave 1
Negrar 1
Parma 1
Philadelphia 1
Pune 1
Redwood City 1
Rotterdam 1
Saga 1
Saint Paul 1
Samarate 1
San Benedetto Del Tronto 1
Senago 1
Shenzhen 1
Stevenage 1
Taicang 1
Tappahannock 1
Totale 2.504
Salva come PNG Salva come JPEG
Nome #
Predittori di efficacia dell’isolamento delle vene polmonari nel trattamento della fibrillazione atriale 212
Hemodynamic sensor in cardiac implantable electric devices: the endocardial accelaration technology 172
Application of the Seattle Heart Failure Model in patients on cardiac resynchronization therapy. 134
Effects of smoking in patients treated with cardiac resynchronization therapy 130
Impact of cardiac resynchronization therapy on the severity of mitral regurgitation. 123
Effects of cryoablation and radiofrequency ablation on endothelial and blood clotting activation 118
Left ventricular mass and progenitor cells in chronic heart failure patients 117
Sleep Disordered Breathing and Arrhythmia Burden in Pacemaker Recipients 115
INSERTION OF A MAGNESIUM(II)-OCTACARBORANYL(HEXYLSULFANYL) PORPHYRAZINE 3 INTO LIPOSOMES: A PHYSICO-CHEMICAL STUDY 115
Metabolomic does not predict response to cardiac resynchronization therapy in patients with heart failure 115
A contribution for validation of ECG criteria for interatrial conduction delay. 112
A real-time three-dimensional echocardiographic validation of an intracardiac electrogram-based method for optimizing cardiac resynchronization therapy. 111
CHADS2 and CHA2DS2-VASc scores to predict morbidity and mortality in heart failure patients candidates to cardiac resynchronization therapy 110
Simplified Selvester Score: a practical electrocardiographic instrument to predict response to CRT 110
Cardiac Resynchronization Therapy Acutely Improves Ventricular-Arterial Coupling by Reducing the Arterial Load: Assessment by Pressure-Volume Loops. 109
Larger interventricular conduction time enhances mechanical response to resynchronization therapy 109
Cardiac resynchronization therapy: gender related differences in left ventricular reverse remodeling. 109
QRS duration in left bundle branch block does not affect left ventricular twisting in chronic systolic heart failure 107
Acute hemodynamic effect of left ventricular endocardial pacing in cardiac resynchronization therapy: assessment by pressure-volume loops. 107
Cardiac memory in humans: vectocardiographic quantification in cardiac resynchronization therapy. 105
Multicenter experience with implantable defibrillators subject to recall. 105
The influence of age on the psychological profile of patients with cardiac implantable electronic devices: results from the Italian population in a multicenter study conducted by the European Heart Rhythm Association 105
Persistent atrial fibrillation in the elderly. A possible association with arterial stiffness, hyperuricemia and chronic inflammation 103
Dual-site left ventricular cardiac resynchronization therapy. 103
Acute effects of His bundle pacing versus left ventricular and right ventricular pacing on left ventricular function. 103
Which factors predict the behavior of ventricular extrasystoles in athletes over time? 100
Atrial fibrillation in recipients of cardiac resynchronization therapy device: 1-year results of the randomized MASCOT trial. 95
Atrial standstill disease progression documented after 13 years follow-up 95
Effectiveness of subcutaneous implantable cardioverter-defibrillator testing in patients with hypertrophic cardiomyopathy 94
Autoantibodies against β1-Adrenergic Receptors: Response to Cardiac Resynchronization Therapy and Renal Function 91
Utility of a new left ventricular asynchrony index as a predictor of reverse remodelling after cardiac resynchronization therapy. 90
Role of natriuretic peptides in heart failure patients with special reference to those on cardiac resynchronization therapy 54
Totale 3.578
Salva come PNG Salva come JPEG
Categoria #
all - tutte 9.532
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 9.532
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020482 0 0 0 0 75 73 78 85 70 45 42 14
2020/2021308 30 36 17 31 14 24 17 37 27 38 16 21
2021/2022236 9 15 17 6 11 12 15 13 12 17 46 63
2022/2023597 55 141 35 32 33 92 84 40 58 4 17 6
2023/2024248 6 29 35 13 23 45 10 63 1 5 11 7
2024/20251.044 57 157 106 299 425 0 0 0 0 0 0 0
Totale 3.578